📰 Iagnostics News
Page 119 - Iagnostics News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Iagnostics. Real-time updates on events, politics, business and more.
December 16, 2021
- Acumen Diagnostics will implement swabbing and COVID-19 PCR tests via Q&M Dental's network of outlets to provide accessible, affordable, and convenient testing services- PCR testing services will be
December 15, 2021
A new study, published on the medRxiv* preprint server, has aimed to determine if children's diet impacts the detection of SARS-CoV-2 virus in saliva. Scientists performed diagnostic tests to detect this virus using real-time self-collected specimens provided by five healthy children. The samples were collected before and after eating selected foods. The specific time of collection of samples after eating were 0 minutes, 20 minutes, and 60 minutes after eating.
December 15, 2021
Researchers directly compare the diagnostic sensitivity of self-collected samples.
December 15, 2021
DGAP-News: Lisen Imprinting Diagnostics Inc / Key word(s): Miscellaneous Lisen Imprinting Diagnostics Announces a Revolutionary Early Diagnostic Method for Lung Cancer 15.12.2021 / 14:00 The issuer is solely responsible for the content of this announcement. Lisen Imprinting Diagnostics Announces...
December 15, 2021
WUXI, CHINA and PHILADELPHIA, PA / ACCESSWIRE / December 15, 2021 / Lisen Imprinting Diagnostics ("LisenID" or "the company") announces an innovative and ground-breaking epigenetics-based diagnostic solution
December 15, 2021
In this interview, News-Medical talks to Dr. Lin Yutao, head of project management at Sino Biological, about the work she does and how Sino provides quick and efficient recombinant CRO services.
December 14, 2021
In a new study in The Journal of Molecular Diagnostics, published by Elsevier, investigators report on the design and testing of a breathalyzer, known as the Bubbler, that relies on viral RNA detection to diagnose SARS-CoV-2.
December 14, 2021
A recent review in the journal Life provided a detailed description of CRISPR-Cas-based diagnostic techniques to identify severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, but also emphasized the potential use of this technology towards developing effective molecular diagnostic platforms for any future pandemic.
December 14, 2021
Dublin, Dec. 14, 2021 (GLOBE NEWSWIRE) -- The "Autoimmune Disease Diagnostic Market Size Global Forecast 2021-2027, Industry Trends, Impact of COVID-19,...
December 14, 2021
Gold Standard Diagnostics continues its response to the threat of the emerging Omicron SARS-CoV-2 variant by providing innovative diagnostic solutions. The Omicron SARS-CoV-2 variant has raised significant